Analyst Consensus ?
1 unmapped firm rating excluded from the percentages.
Mettler-Toledo International Inc. · MTD · FY2025 Q4 · Calendar Q1 2026
The latest analysis supports a constructive but qualified view: Mettler-Toledo is showing resilient demand in automation, digitalization, service, and onshoring-related areas, while unchanged guidance and ongoing tariff, foreign-exchange, China, and end-market risks temper the outlook.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Compared with the prior analysis, Q4 growth was 5% in local currency, the service business reached $1 billion, and management highlighted the Vero pipette and X3 Series X-ray launches. The Swiss tariff rate reduction was identified as a near-1% 2026 EPS benefit, while tariff and FX pressures remained.
Maintained: full-year 2026 guidance was unchanged, with approximately 4% local-currency sales growth, operating margin up 60–70 basis points, and adjusted EPS of $46.05–$46.70.
Follow MTD with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 free1 unmapped firm rating excluded from the percentages.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 30, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Aug 4, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Aug 3, 2026 |
| Stifel | Buy | Buy | Maintain | Aug 3, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Aug 3, 2026 |
| Barclays | Overweight | Overweight | Maintain | Aug 3, 2026 |
| Jefferies | Buy | Buy | Maintain | Jul 31, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | May 11, 2026 |
| Baird | Neutral | Neutral | Maintain | May 11, 2026 |
| Citigroup | Buy | Buy | Maintain | May 8, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | Sep 22, 2025 |
| UBS | Buy | Neutral | Upgrade | May 20, 2025 |
| Goldman Sachs | Neutral | Neutral | Maintain | Jul 9, 2024 |
| CFRA | Hold | Hold | Maintain | May 8, 2020 |
| Bank of America | Neutral | Buy | Downgrade | Jan 3, 2019 |
| Deutsche Bank | Hold | Hold | Maintain | May 4, 2018 |
| Cantor Fitzgerald | Buy | Buy | Maintain | Jul 28, 2014 |
| Credit Agricole | Outperform | Underperform | Upgrade | Feb 7, 2013 |
| CL King | Neutral | Buy | Downgrade | Dec 19, 2012 |
| ISI Group | Underweight | Upgrade | Jul 27, 2012 |
Upside is calculated against the persisted current price $1,510.95. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| RBC Capital | Dan Leonard | $1,515 | $1,405.14 | +0.3% | Sep 1, 2026 |
| Morgan Stanley | Kallum Titchmarsh | $1,450 | $1,433.89 | -4.0% | Aug 4, 2026 |
| Barclays | Analyst unavailable | $1,575 | $1,416.3 | +4.2% | Aug 3, 2026 |
| Stifel Nicolaus | Daniel Arias | $1,600 | $1,416.3 | +5.9% | Aug 3, 2026 |
| Jefferies | Analyst unavailable | $1,580 | $1,412.91 | +4.6% | Jul 31, 2026 |
| Evercore ISI | Analyst unavailable | $1,350 | $1,292.74 | -10.7% | Jul 6, 2026 |
| Stifel Nicolaus | Daniel Arias | $1,400 | $1,031.64 | -7.3% | May 18, 2026 |
| Robert W. Baird | Analyst unavailable | $1,194 | $1,124.46 | -21.0% | May 11, 2026 |
| Barclays | Analyst unavailable | $1,500 | $1,345.89 | -0.7% | Apr 14, 2026 |
| Morgan Stanley | Kallum Titchmarsh | $1,475 | $1,382.72 | -2.4% | Feb 9, 2026 |
| Robert W. Baird | Catherine Ramsey Schulte | $1,445 | $1,373.57 | -4.4% | Feb 9, 2026 |
| Wells Fargo | Analyst unavailable | $1,450 | $1,393.64 | -4.0% | Dec 15, 2025 |
| Susquehanna | Analyst unavailable | $1,600 | $1,393.64 | +5.9% | Dec 15, 2025 |
| Barclays | Analyst unavailable | $1,550 | $1,393.64 | +2.6% | Dec 15, 2025 |
| Goldman Sachs | Analyst unavailable | $1,475 | $1,381.37 | -2.4% | Dec 9, 2025 |
| Morgan Stanley | Kallum Titchmarsh | $1,550 | $1,468.09 | +2.6% | Dec 1, 2025 |
| Evercore ISI | Analyst unavailable | $1,400 | $1,345.27 | -7.3% | Oct 7, 2025 |
| Barclays | Analyst unavailable | $1,350 | $1,289.82 | -10.7% | Oct 2, 2025 |
| Barclays | Analyst unavailable | $1,325 | $1,185.18 | -12.3% | Jun 24, 2025 |
| UBS | Dan Leonard | $1,350 | $1,159.1 | -10.7% | May 19, 2025 |
| Jefferies | Tycho Peterson | $1,100 | $1,100.01 | -27.2% | May 4, 2025 |
| Robert W. Baird | Analyst unavailable | $1,034 | $1,003.16 | -31.6% | Apr 22, 2025 |
| Stifel Nicolaus | Daniel Arias | $1,450 | $1,378.34 | -4.0% | Nov 11, 2024 |
| Stifel Nicolaus | Daniel Arias | $1,550 | $1,441.43 | +2.6% | Aug 5, 2024 |
| Robert W. Baird | Catherine Schulte | $1,375 | $1,441.43 | -9.0% | Aug 5, 2024 |
| Jefferies | Tycho Peterson | $1,250 | $1,404.09 | -17.3% | Jun 3, 2024 |
| Stifel Nicolaus | Daniel Arias | $1,510 | $1,510.25 | -0.1% | May 13, 2024 |
| Robert W. Baird | Catherine Schulte | $1,360 | $1,449.38 | -10.0% | May 13, 2024 |
| Stifel Nicolaus | Daniel Arias | $1,500 | $1,195.02 | -0.7% | Sep 6, 2022 |
| UBS | Elizabeth Garcia | $1,237 | $1,349.73 | -18.1% | Jul 31, 2022 |
| Wells Fargo | Analyst unavailable | $1,410 | $1,284.63 | -6.7% | Apr 25, 2022 |
Track every rating change on MTD the moment it posts. Free to start.
Start freeMettler-Toledo International Inc. (MTD) is a global enterprise dedicated to the production and provision of precision instruments and related services. The company's operations are strategically organized across five geographical divisions: its domestic U.S. market, Swiss operations, Western European activities, Chinese operations, and an 'Other' segment covering remaining territories. Their extensive product portfolio serves diverse scientific and industrial needs. Within the laboratory sphere, Mettler-Toledo supplies a comprehensive array of equipment, including high-precision balances, advanced liquid handling systems (such as pipetting solutions), automated laboratory reactors, titrators, pH meters, sensors and analyzers for process analytics, instruments for evaluating physical properties, thermal analysis systems, and various other analytical tools. These hardware offerings are complemented by LabX, their proprietary software platform designed for managing and analyzing instrument-generated data.…
| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| COO The Cooper Companies, Inc. | FY2026 Q3 · Calendar Q3 2026 | +2.7% | -14.7% | CooperCompanies beats expectations as inventory reduction weighs on vision revenue |
| MDT Medtronic plc | FY2027 Q1 · Calendar Q3 2026 | +4.3% | +1.5% | Medtronic raises FY27 outlook as growth broadens across platforms |
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-09-30. For educational purposes only; not investment advice.